| Literature DB >> 28701166 |
Agnes Luzak1, Elaine Fuertes1,2,3,4, Claudia Flexeder1, Marie Standl1, Andrea von Berg5, Dietrich Berdel5, Sibylle Koletzko6, Joachim Heinrich1,7,8, Dennis Nowak7,8, Holger Schulz9,10.
Abstract
BACKGROUND: Various factors may affect lung function at different stages in life. Since investigations that simultaneously consider several factors are rare, we examined the relative importance of early life, current environmental/lifestyle factors and allergic diseases on lung function in 15-year-olds.Entities:
Keywords: Adolescence; Determinants; Epidemiology; Lung function; Spirometry
Mesh:
Substances:
Year: 2017 PMID: 28701166 PMCID: PMC5508705 DOI: 10.1186/s12931-017-0619-5
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Fig. 1Covariates investigated for association with lung function in 15-year old adolescents (definitions presented in Table 1)
Definition of early life events, environmental and lifestyle factors, and allergic diseases at age 15
| Definition | Assessment | |
|---|---|---|
| Early life events | ||
| Parental atopy | positive if the mother or father had asthma, eczema or hay fever | asked at birth; questionnaire-based |
| Parental education | three categories based on the highest number of education years of either parent (high: >10 years; medium: 10 years; low: <10 years) | asked at birth; questionnaire-based |
| Maternal age at delivery | dichotomized in ≤31 years and >31 years (mean age served as cut-off) | asked at birth; questionnaire-based |
| Maternal smoking during pregnancy | yes vs no | asked at birth; questionnaire-based |
| Early second-hand smoke exposure at home | positive if parents reported at least once that the child was exposed to second-hand smoke at home | asked up to age 4 (at 4 months, 1 year (control arm only) and yearly at 2 to 4 years in GINIplus; half-yearly from birth to 2 years and at age 4 years for past 24 months in LISAplus); questionnaire-based |
| Season of birth | dichotomized (December to February (winter) versus other seasons) | Birth month derived from date of birth; questionnaire-based |
| Birth weight | continuous, grams | asked at birth in LISAplus and at 1 year in GINIplus; questionnaire-based |
| Breastfeeding | exclusive breastfeeding for at least four months | asked separately for 1–6 months at 1 year in GINIplus and at 6 months in LISAplus; questionnaire-based |
| Peak weight and peak height velocity | maximum of the first derivative of the individual weight or height gain curves obtained between birth and two years of age (calculated using nonlinear random effects models) [ | weight and height measurements obtained during the children’s preventive medical check-ups to monitor growth |
| Early lower respiratory tract infections | doctor’s diagnosis of pneumonia or obstructive bronchitis within the first three years of life (hereon referred to as lung infections) | asked up to age 3 (yearly in GINIplus; half-yearly up to age 2 years and up to age 3 years asked at the 4 year follow-up in LISAplus); questionnaire-based |
| Environmental and lifestyle factors at age 15 | ||
| Short-term air pollution exposure | continuous, the average of the daily concentrations of NO2, PM2.5 mass and PM10 mass (μg/m3) | obtained for the seven days prior to lung function testing from monitoring sites near the centers of Munich and Wesel [ |
| Long-term air pollution exposure | continuous, long-term concentrations of NO2, PM2.5 mass and PM10 mass (μg/m3) | estimated to each participant’s home address at birth, 10- and 15-years, respectively [ |
| Regular indoor second-hand smoke exposure | positive if the adolescent reported indoor second-hand smoke exposure at least once a week | asked at age 15 years; one question in GINIplus, two questions for second-hand exposure: (1) at home and (2) in other locations in LISAplus (positive if regular exposure was reported in at least one question); questionnaire-based |
| Active smoking | yes vs no | asked at age 15 years, questionnaire-based |
| Vitamin D concentrations | continuous; serum 25-hydroxyvitamin D [25(OH)D] concentrations adjusted for seasonal variance using a generalized additive model (nmol/l) [ | measured at age 15 years using Roche’s vitamin D total test (E170, Roche Diagnostics, Mannheim, Germany) |
| Body mass index | continuous, kilogram per square meter (kg/m2) | calculated using body height and weight obtained at lung function testing |
| Current allergic diseases | ||
| Asthma | defined based on the Global Allergy and Asthma European Network (GA2LEN) definition [ | parents were asked to provide yearly information on their child’s doctor diagnosed allergic diseases throughout childhood; information on current allergic symptoms and asthma medication in the last 12 months was derived from the last follow-up questionnaire at age 15 years. |
| Current allergic rhinitis | positive if one of the following questions was positive: (1) Has a doctor diagnosed hay fever (i.e. seasonal allergic rhinitis) in your child? (2) Has a doctor diagnosed perennial allergic rhinitis in your child? | asked separately for ages 11 to 15, at the 15-year follow-up;questionnaire-based |
| Sensitization to food or aeroallergens | food allergen mixture including egg white, codfish, cow milk, wheat flour, peanut, and soybean and aeroallergen mixture including cat, dog, mugwort, birch, timothy, rye, | measured by serum specific Immunoglobulin E (IgE) using the ImmunoCAP Specific IgE system (Phadia GmbH, Freiburg, Germany) at age 15 years |
GINIplus: German Infant study on the influence of Nutrition Intervention plus air pollution and genetics on allergy development; LISAplus: Life-style related factors on the development of the Immune System and Allergies in East and West Germany plus the influence of traffic emissions and genetics
Population characteristics of analyzed subjects.
| Total | Males | Females | |
| % ( | 100 (1326) | 51.1 (678) | 48.9 (648) |
| Mean (SD) or % ( | |||
| Age, years | 15.2 (0.3) | 15.2 (0.3) | 15.2 (0.3) |
| Height*, cm | 172 (8.2) | 176 (7.4) | 167 (6.0) |
| Study specific | |||
| Study | |||
| GINIplus control | 38.3 (508) | 38.2 (259) | 38.4 (249) |
| GINIplus intervention | 34.5 (457) | 33.8 (229) | 35.2 (228) |
| LISAplus | 27.2 (361) | 28.0 (190) | 26.4 (171) |
| Study center | |||
| Munich | 63.3 (840) | 63.1 (428) | 63.6 (412) |
| Wesel | 36.7 (486) | 36.9 (250) | 36.4 (236) |
| Early life events | |||
| Parental atopy, yes | 58.8 (780) | 57.7 (391) | 60.0 (389) |
| Parental education | |||
| low (< 10 years of school) | 5.2 (69) | 5.8 (39) | 4.6 (30) |
| medium (= 10 years of school) | 26.7 (354) | 27.0 (183) | 26.4 (171) |
| high (> 10 years of school) | 68.1 (903) | 67.3 (456) | 69.0 (447) |
| Maternal age at delivery >31 years*, yes | 49.9 (662) | 46.3 (314) | 53.7 (348) |
| Maternal smoking during pregnancy, yes | 12.0 (159) | 11.9 (81) | 12.0 (78) |
| Early second-hand smoke exposure at home (up to age 4), yes | 32.7 (433) | 32.6 (221) | 32.7 (212) |
| Season of birth, winter | 25.6 (339) | 24.5 (166) | 26.7 (173) |
| Birth weight*, g | 3483 (442.0) | 3541 (443.5) | 3422 (432.6) |
| Exclusive breastfeeding >4 months, yes | 60.6 (804) | 58.3 (395) | 63.1 (409) |
| Peak weight velocity*, kg/month | 1.1 (0.2) | 1.2 (0.2) | 1.0 (0.2) |
| Peak height velocity*, cm/month | 3.6 (0.4) | 3.8 (0.4) | 3.5 (0.4) |
| Lung infections (up to age 3)*, yes | 31.2 (414) | 34.8 (236) | 27.5 (178) |
| Environmental and lifestyle factors at age 15 | |||
| Short-term air pollution | |||
| NO2 (μg/m3) | 20.4 (6.9) | 20.5 (7.0) | 20.3 (6.7) |
| PM2.5 mass (μg/m3) | 14.7 (7.3) | 14.4 (6.7) | 15.0 (7.9) |
| PM10 mass (μg/m3) | 18.9 (7.8) | 18.6 (7.2) | 19.3 (8.4) |
| Long-term air pollution | |||
| NO2 (μg/m3) | 21.2 (4.8) | 21.2 (5.0) | 21.2 (4.6) |
| PM2.5 mass (μg/m3) | 14.8 (2.1) | 14.8 (2.2) | 14.8 (2.1) |
| PM10 mass (μg/m3) | 22.1 (3.2) | 22.0 (3.3) | 22.1 (3.2) |
| Regular indoor second-hand smoke exposurea, yes | 20.1 (266) | 19.0 (129) | 21.1 (137) |
| Active smoking, yes | 5.4 (71) | 5.6 (38) | 5.1 (33) |
| Serum vitamin Db, nmol/l | 68.4 (25.3) | 67.5 (24.3) | 69.3 (26.2) |
| Body mass index*, kg/m2 | 20.7 (3.0) | 20.7 (3.2) | 20.8 (2.8) |
| Allergic diseases at age 15 | |||
| Asthma, yes | 6.3 (83) | 7.4 (50) | 5.1 (33) |
| Rhinitis, yes | 18.9 (251) | 20.9 (142) | 16.8 (109) |
| Sensitization to | |||
| Aeroallergens*, yes | 45.4 (602) | 51.5 (349) | 39.0 (253) |
| Food allergens, yes | 11.2 (148) | 12.8 (87) | 9.4 (61) |
| Spirometric parameters at age 15 | |||
| FVC, l* | 4.08 (0.77) | 4.50 (0.74) | 3.64 (0.51) |
| FEV1, l* | 3.52 (0.63) | 3.83 (0.64) | 3.19 (0.42) |
| FEV1/FVC, %* | 86.7 (6.39) | 85.3 (6.43) | 88.1 (6.02) |
| PEF, l/s* | 7.15 (1.28) | 7.73 (1.3) | 6.54 (0.93) |
| FEF25, l/s* | 6.26 (1.17) | 6.61 (1.27) | 5.89 (0.92) |
| FEF50, l/s* | 4.46 (1.05) | 4.71 (1.14) | 4.19 (0.87) |
| FEF75, l/s* | 2.21 (0.72) | 2.31 (0.78) | 2.11 (0.63) |
| FEF25–75, l/s* | 3.92 (0.92) | 4.12 (1.01) | 3.70 (0.77) |
*Significant difference (p-value < 0.05) between males and females (t-test, Wilcoxon rank-sum test, or chi-square test)
aat least once a week or more. bseason-adjusted 25(OH)D concentration
FEV1: forced expiratory volume in 1 s. FVC: forced vital capacity. FEF25, FEF50, FEF75: forced expiratory flow rates at 25, 50 and 75% of exhaled FVC. FEF25–75: mean flow rate between 25 and 75% of FVC. PEF: peak expiratory flow. SD: standard deviation
Coefficients (95%-confidence intervals) of regression models adjusted for covariates that remained stable in replication analyses
| Spirometric parameter indicative of | Lung volume | Airways & volume | Airflow limitation | Airways |
|---|---|---|---|---|
| FVC, ml | FEV1, ml | FEV1/FVC, % | FEF25–75, ml/s | |
| Sex, male | 347 (289, 405) | 220 (167, 274) | −2.2 (−2.9,-1.4) | |
| Age, IQR years | 47 (26, 69) | 30 (11, 50) | ||
| Height, IQR cm | 637 (598, 676) | 517 (481, 553) | 508 (438, 577) | |
| Early life events | ||||
| Peak weight velocity, IQR kg/month | −0.8 (−1.3, −0.3) | −88 (−155, −20) | ||
| Lung infections (up to age 3), yes | −55 (−102, −7) | −1.1 (−1.8,-0.3) | −159 (−258, −60) | |
| Environment & lifestyle at age 15 | ||||
| Regular indoor second-hand smoke exposurea, yes | −59 (−114, −5) | |||
| Serum vitamin Db, IQR nmol/l | 65 (34, 96) | 32 (3, 61) | −0.6 (−1, −0.2) | |
| Body mass index, IQR kg/m2 | 222 (194, 250) | 144 (118, 171) | −1.2 (−1.6,-0.8) | 85 (31, 140) |
| Allergic diseases at age 15 | ||||
| Asthma, yes | −118 (−216, −21) | −177 (−268, −86) | −1.8 (−3.1,-0.4) | −304 (−494, −115) |
| Study specific | ||||
| Study (LISAplus vs GINIplus) | 68 (12, 124) | |||
| Study center (Wesel vs Munich) | −66 (−119, −13) | −135 (−182, −88) | −1.6 (−2.3,-0.9) | −256 (−352, −161) |
All associations were statistically significant (p-value < 0.05). Estimates for continuous variables are presented per interquartile range (IQR) increase (IQR: age (0.26 years), height (11 cm), peak weight velocity (0.28 kg/month), vitamin D (32.35 nmol/l), body mass index (3.56 kg/m2))
aat least once a week or more. bseason-adjusted 25(OH)D concentration. FEV1: forced expiratory volume in 1 s. FVC: forced vital capacity. FEF25–75: mean flow rate between 25 and 75% of FVC
Relative importance of variables in final regression models (averaged R contribution)
Relative importance of variables in regression models adjusted for covariates that remained stable in replication analyses are displayed as normalized percent of R contribution averaged (unweighted) over variable orderings.
1at least once a week or more. 2season-adjusted 25(OH)D concentration. FEV1: forced expiratory volume in 1 s. FVC: forced vital capacity. FEF25–75: mean flow rate between 25 and 75% of FVC